Palliative Management of Inoperable Malignant Bowel Obstruction
Palliative Management of Inoperable Malignant Bowel Obstruction: A Prospective, Open Label, Phase-2 Study at an NCI Comprehensive Cancer Center
Sponsor: Roswell Park Cancer Institute
Terminated
low accrual
Other terminated trials from Roswell Park Cancer Institute
A PHASE2 clinical study on Malignant Bowel Obstruction, this trial is terminated or withdrawn. The trial is conducted by Roswell Park Cancer Institute and has accumulated 12 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2022 — Dec 2022 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Feb 2022 — Jun 2022 [monthly]
Active Not Recruiting PHASE2
▶ Show 7 earlier versions
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
May 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Mar 2021 — May 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Aug 2019 — Mar 2020 [monthly]
Recruiting PHASE2
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Roswell Park Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .